Squarepoint’s Mesoblast MESO Stock Holding History

Squarepoint’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Sell	17,402 -16,640	-49%	-$247K	﹤0.01%	3970
2026 Q1	$524K	Buy	34,042 +15,463	+83%	+$257K	﹤0.01%	3306
2025 Q4	$335K	Sell	18,579 -13,077	-41%	-$225K	﹤0.01%	3511
2025 Q3	$510K	Buy	31,656 +17,053	+117%	+$249K	﹤0.01%	3218
2025 Q2	$159K	Sell	14,603 -457	-3%	-$5.12K	﹤0.01%	4047
2025 Q1	$188K	Buy	+15,060	New	+$248K	﹤0.01%	4035
2021 Q2	–	Sell	-7,409	Closed	-$123K	–	3509
2021 Q1	$123K	Buy	+7,409	New	+$140K	﹤0.01%	2854

Other funds holding MESO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

FFA

Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

Squarepoint's MESO Position: Q2 2026 in Review

Squarepoint reduced its Mesoblast (MESO) stake by 49% in Q2 2026, selling an estimated $247K and leaving 17,402 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #3970.

Squarepoint first reported a position in MESO in Q1 2021 and has held it in 7 quarters since. The position peaked at $524K in Q1 2026. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

Squarepoint held 17,402 shares of Mesoblast worth $235K as of Q2 2026.
Squarepoint sold 16,640 Mesoblast shares in Q2 2026, an estimated $247K.
Mesoblast made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3970 holding.
Squarepoint first reported a position in Mesoblast in Q1 2021 and has held it in 7 quarters since.
Squarepoint's Mesoblast position peaked at $524K in Q1 2026.
72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.